Company news
BioAge Labs, Inc. news in 2024
BioAge Labs, Inc.'s news releases, calls and decks from 2024, newest first.
BioAge Labs Announces Multi-Year Collaboration with Novartis to Discover Novel Targets for Therapies that Address Age-Related Diseases and Conditions
December 17, 2024
BioAge Labs Announces Discontinuation of STRIDES Phase 2 Clinical Trial Evaluating Azelaprag in Combination with Tirzepatide for the Treatment of Obesity
December 5, 2024
BioAge Labs to Present at Goldman Sachs “Year-Ahead” Catalyst Clinic
December 4, 2024
BioAge Labs Reports Third Quarter 2024 Financial Results and Provides Business Updates
November 6, 2024
BioAge Labs to Present Preclinical Data for APJ Agonist Azelaprag at ObesityWeek 2024
November 3, 2024
BioAge Labs to Present at Jefferies London Healthcare Conference
October 23, 2024
BioAge Labs Announces Closing of Initial Public Offering, Full Exercise of Underwriters’ Option to Purchase Additional Shares and Closing of the Concurrent Private Placement
September 30, 2024
BioAge Labs Announces Pricing of Upsized Initial Public Offering
September 24, 2024